Document Detail


Pancreatic stone protein as a novel marker for neonatal sepsis.
MedLine Citation:
PMID:  23296629     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: Early-onset sepsis (EOS) is one of the main causes for the admission of newborns to the neonatal intensive care unit. However, traditional infection markers are poor diagnostic markers of EOS. Pancreatic stone protein (PSP) is a promising sepsis marker in adults. The aim of this study was to investigate whether determining PSP improves the diagnosis of EOS in comparison with other infection markers. METHODS: This was a prospective multicentre study involving 137 infants with a gestational age of >34 weeks who were admitted with suspected EOS. PSP, procalcitonin (PCT), soluble human triggering receptor expressed on myeloid cells-1 (sTREM-1), macrophage migration inhibitory factor (MIF) and C-reactive protein (CRP) were measured at admission. Receiver-operating characteristic (ROC) curve analysis was performed. RESULTS: The level of PSP in infected infants was significantly higher than that in uninfected ones (median 11.3 vs. 7.5 ng/ml, respectively; p = 0.001). The ROC area under the curve was 0.69 [95 % confidence interval (CI) 0.59-0.80; p < 0.001] for PSP, 0.77 (95 % CI 0.66-0.87; p < 0.001) for PCT, 0.66 (95 % CI 0.55-0.77; p = 0.006) for CRP, 0.62 (0.51-0.73; p = 0.055) for sTREM-1 and 0.54 (0.41-0.67; p = 0.54) for MIF. PSP independently of PCT predicted EOS (p < 0.001), and the use of both markers concomitantly significantly increased the ability to diagnose EOS. A bioscore combining PSP (>9 ng/ml) and PCT (>2 ng/ml) was the best predictor of EOS (0.83; 95 % CI 0.74-0.93; p < 0.001) and resulted in a negative predictive value of 100 % and a positive predictive value of 71 %. CONCLUSIONS: In this prospective study, the diagnostic performance of PSP and PCT was superior to that of traditional markers and a combination bioscore improved the diagnosis of sepsis. Our findings suggest that PSP is a valuable biomarker in combination with PCT in EOS.
Authors:
Luregn J Schlapbach; Rolf Graf; Andreas Woerner; Matteo Fontana; Urs Zimmermann-Baer; David Glauser; Eric Giannoni; Thierry Roger; Christoph Müller; Mathias Nelle; Martin Stocker
Related Documents :
18644009 - Comparison of chlorpromazine versus morphine hydrochloride for treatment of neonatal ab...
11851579 - Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in...
22339399 - Clinical application of metabolomics in neonatology.
24389019 - Interferon lambda 1-3 expression in infants hospitalized for rsv or hrv associated bron...
24566529 - Maternal and paternal satisfaction in the delivery room: a cross-sectional comparative ...
25432659 - Epidural analgesia, neonatal care and breastfeeding.
8304019 - Outcome for fetuses with abdominal wall defects detected by routine second trimester ul...
2563419 - Morbidity of very low birthweight infants at corrected age of two years in a geographic...
15838749 - Complement 4 levels as early predictors of poor response to surfactant therapy in respi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-8
Journal Detail:
Title:  Intensive care medicine     Volume:  -     ISSN:  1432-1238     ISO Abbreviation:  Intensive Care Med     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7704851     Medline TA:  Intensive Care Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Neonatal and Pediatric Intensive Care Unit, Department of Paediatrics, University of Berne, Bern, Switzerland, luregn.schlapbach@mater.org.au.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predictors of external cooling failure after cardiac arrest.
Next Document:  Assessment of the inflammatory effect of low-dose oxygen in mechanically ventilated patients.